A double-masked randomized multi-center active-controlled parallel 12-month study assessing the safety and ocular hypotensive efficacy of AR-13324 Ophthalmic Solution 0.02% q.d. and b.i.d. compared to Timolol Maleate Ophthalmic Solution 0.5% b.i.d. in patients with elevated intraocular pressure
-
- STATUS
- Not Recruiting
Summary
The purpose of this research study is to test the effectiveness and safety of AR13324 Ophthalmic Solution 0.02%, once daily, and AR13324 Ophthalmic Solution 0.02%, twice daily, relative to Timolol Maleate 0.5% which is commercially available for lowering of intraocular pressure in patients with glaucoma or ocular hypertension (raised intraocular pressure).
Description
The purpose of this research study is to test the effectiveness and safety of AR13324 Ophthalmic Solution 0.02%, once daily, and AR13324 Ophthalmic Solution 0.02%, twice daily, relative to Timolol Maleate 0.5% which is commercially available for lowering of intraocular pressure in patients with glaucoma or ocular hypertension (raised intraocular pressure).
Details
| Condition | glaucoma,ocular hypertension |
|---|---|
| Age | 18years - 100years |
| Clinical Study Identifier | TX4218 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.